Hutch News
Search and Filter
Results per Page:
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
Like snowflakes, no two cells are alike
Study shows that differences in cells’ ability to turn genes into proteins change how mutations manifest; offers insights into disease risk
Largest single-year drop in cancer death rates continues encouraging trend
Stat reflects decrease in deaths from top 4 cancers; masks lack of progress in others
Dr. Thomas J. Lynch Jr. named new president and director of Fred Hutch
Oncologist, scientist and cancer center leader brings 30 years of experience in academic medicine
CRISPR-based tool solves genetic mystery 80 million years in the making
Certain DNA sequences haven’t evolved since humans and mice diverged. But why?
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
A 'historic victory,' say experts, as US raises age to buy tobacco, vaping products to 21 nationwide
Here's the scientific evidence for why this change will save lives — and what steps might be next
Fred Hutch science and research highlights 2019
Articles showcasing some of the most significant advances in immunotherapy, cell biology and more
Study links common immune cell to failure of checkpoint inhibitors in lung cancer
New research suggests how to better predict which patients will respond to immunotherapy
Philanthropic support catalyzes audacious ideas, bold research
Support from thousands of donors gives researchers the time and resources they need to advance high-risk projects with immense potential
What's new in breast cancer research: #SABCS19 edition
Fred Hutch researchers share long-term follow-up data on WHI hormone study, anti-hormone side effect strategies and more at San Antonio meeting
2 Fred Hutch leaders receive PSBJ Health Care Leadership Awards
Puget Sound Business Journal honors Drs. Gary Gilliland, Nancy Davidson among 16 regional health care leaders
'Big, brave ideas': 44th annual Hutch Holiday Gala raises over $13 million
Community steps up to fuel the leading edge of cancer research
Gimme shelter: CRISPR hides healthy cells from leukemia drug
In mouse study, gene-edited cells stay safe as immunotherapy attacks cancer
Cancer immunotherapy gets assist from micro-scale engineering
With new molecular 'handles' and stimulating signals, metallic thin films become a stronghold for cancer-killing immune cells
Try, try again: Can a 2nd dose of CAR T cells succeed when the first fails?
First-of-its-kind study offers early indication of factors linked to increased odds of success for patients out of options
World AIDS Day: Stepping up the search for a cure
New funding from Gates Foundation and NIH give vote of confidence for an audacious goal
Black men with early-stage prostate cancer can do active surveillance
New study using Canary PASS data shows African American men with low-risk disease can delay radical treatment just like white men
Fred Hutch paleovirologist elected AAAS fellow
American Association for the Advancement of Science honors Dr. Harmit Malik for applying evolutionary theories of genetic conflict to new biological processes
Fred Hutch receives 5 years of NCI funding to grow and maintain key prostate cancer cohort
$6.7M grant will boost size, participant diversity of Canary Prostate Active Surveillance Study